Global RNA-interference (RNAi) Market Share

Statistics for the 2023 & 2024 Global RNA-interference (RNAi) market share, created by Mordor Intelligence™ Industry Reports. Global RNA-interference (RNAi) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Biotechnology Research Biotechnology R&D Research Life Science Research Technologies Research RNAi Technology Research RNAi Technology Market Market Share

Market Share of Global RNA-interference (RNAi) Industry

The RNA-interference (RNAi) market is highly competitive and consists of a few major players. Companies like Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals (Novo Nordisk A/S), Thermofisher Scientific, Silence Therapeutics PLC, among others, hold a substantial market share in the RNA-interference (RNAi) market.

RNAi Technology Market Leaders

  1. Alnylam Pharmaceuticals

  2. Silence Therapeutics PLC

  3. Arrowhead Pharmaceuticals, Inc.

  4. Thermo Fisher Scientific Inc

  5. Dicerna Pharmaceuticals (Novo Nordisk A/S)

*Disclaimer: Major Players sorted in no particular order

Picture1.png

RNAi Technology Market Report Snapshots

RNAi Technology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)